Synthetic biology: bottom-up assembly of molecular systems

S Hirschi, TR Ward, WP Meier, DJ Müller… - Chemical …, 2022 - ACS Publications
The bottom-up assembly of biological and chemical components opens exciting
opportunities to engineer artificial vesicular systems for applications with previously unmet …

Pathological angiogenesis and inflammation in tissues

JH Jeong, U Ojha, YM Lee - Archives of Pharmacal Research, 2021 - Springer
The role of angiogenesis in the growth of organs and tumors is widely recognized. Vascular–
organ interaction is a key mechanism and a concept that enables an understanding of all …

Liposomes: From bangham to supercritical fluids

P Trucillo, R Campardelli, E Reverchon - Processes, 2020 - mdpi.com
Liposomes are spherical vesicles made up of an aqueous core surrounded by
phospholipids. These delivery systems (DS) are largely employed as drug carriers in several …

Controlled biosynthesis of gold nanoparticles with Coffea arabica using factorial design

WJ Keijok, RHA Pereira, LAC Alvarez, AR Prado… - Scientific Reports, 2019 - nature.com
Green synthesis of metallic nanoparticles has become incredibly popular, mainly by
minimizing problems of environmental contamination and by being able to reduce, stabilize …

Synthesis, functionalization, and nanomedical applications of functional magnetic nanoparticles

Z Chen, C Wu, Z Zhang, W Wu, X Wang, Z Yu - Chinese Chemical Letters, 2018 - Elsevier
Synthesis of magnetic nanoparticles (MNPs) is one of the most active research areas in
advanced materials. MNPs that have magnetic properties and other functionalities have …

Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models

M He, L Yu, Y Yang, B Zou, W Ma, M Yu, J Lu… - Chinese Chemical …, 2020 - Elsevier
Hepatocellular carcinoma (HCC) has become the fourth predominant cause of cancer-
related deaths worldwide, and HCC is still one of the worst prognoses for survival as it is …

[HTML][HTML] Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy

Y Sun, W Ma, Y Yang, M He, A Li, L Bai, B Yu… - Asian journal of …, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is one of the deadliest cancers due to its complexities,
reoccurrence after surgical resection, metastasis and heterogeneity. In addition to sorafenib …

Drug delivery in cancer therapy, quo vadis?

ZR Lu, P Qiao - Molecular Pharmaceutics, 2018 - ACS Publications
The treatment of malignancies has undergone dramatic changes in the past few decades.
Advances in drug delivery techniques and nanotechnology have allowed for new …

Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer

M Azari, F Bahreini, VN Uversky, N Rezaei - Biochemical Pharmacology, 2023 - Elsevier
Breast cancer is a collation of malignancies that manifest in the mammary glands at the early
stages. Among breast cancer subtypes, triple-negative breast cancer (TNBC) shows the …

A modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatment

Q Meng, H Hu, X Jing, Y Sun, L Zhou, Y Zhu… - Journal of Controlled …, 2021 - Elsevier
Traditional and single treatment strategies are difficult to achieve good results due to tumor
resistance and complex mechanisms. Combination therapy through co-delivery systems is …